Aviva PLC
26 September 2007
Aviva plc
26 September 2007
Scrip Dividend Scheme
The scrip dividend calculation price for the 2007 interim dividend payable on 16
November 2007 is 695.9p. This is the reference price at which Aviva plc
ordinary shares will be issued to shareholders who have elected to take shares
in lieu of cash dividends through participation in the Aviva Scrip Dividend
Scheme. This price is based on the average of the middle market quotations of
Aviva plc ordinary shares derived from the London Stock Exchange Daily Official
List for the five consecutive business days 19 - 25 September 2007 inclusive.
Any shareholders who do not already participate in the Aviva Scrip Dividend
Scheme and wish to do so, should contact the Company's Registrar, Lloyds TSB
Registrars on 0870 600 3952 to obtain a mandate form. This form must be
returned to Lloyds TSB Registrars to arrive by no later than 5pm on 19 October
2007 in order for it to be effective for the 2007 interim dividend.
END
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.